MCS Medical Compression Systems is a leader in the field of non-invasive blood circulation solutions through a pneumatic device. The company has developed a device to prevent Deep Vein Thrombosis (DVT) as a result of trauma or surgical intervention. MCS is the first company to offer the international medical market a non-invasive blood circulation solution that can replace the medication therapy that is currently the standard treatment. The company’s technologies and product lines are protected by numerous patents and are internationally certified with FDA and CE approvals.
Founded in 1997, MCS is an Israeli public company, traded on the Tel Aviv Stock Exchange (TASE:MDCL). The company’s management and R&D are headquartered in Israel with manufacturing facilities located in both Israel and the US. The company’s sales and marketing teams are managed in the US by its subsidiary, MCS Inc., which conducts in-depth training and support programs to distributors and medical facilities throughout the country.